News | January 08, 2025
Ajooni Biotech to raise Rs. 45 crore through convertible warrants
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Subscribe To Our Newsletter & Stay Updated
